- Home
- ASRT vs MYO Comparison
ASRT vs MYO Comparison
Compare ASRT & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- MYO
- Stock Information
- Founded
- ASRT 1995
- MYO 2004
- Country
- ASRT United States
- MYO United States
- Employees
- ASRT N/A
- MYO N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- MYO Industrial Specialties
- Sector
- ASRT Health Care
- MYO Health Care
- Exchange
- ASRT Nasdaq
- MYO Nasdaq
- Market Cap
- ASRT 57.9M
- MYO 153.0M
- IPO Year
- ASRT 1997
- MYO 2017
- Fundamental
- Price
- ASRT $0.63
- MYO $2.13
- Analyst Decision
- ASRT Strong Buy
- MYO Strong Buy
- Analyst Count
- ASRT 2
- MYO 4
- Target Price
- ASRT $3.25
- MYO $9.13
- AVG Volume (30 Days)
- ASRT 248.2K
- MYO 815.7K
- Earning Date
- ASRT 08-06-2025
- MYO 08-05-2025
- Dividend Yield
- ASRT N/A
- MYO N/A
- EPS Growth
- ASRT N/A
- MYO N/A
- EPS
- ASRT N/A
- MYO N/A
- Revenue
- ASRT $119,001,000.00
- MYO $38,628,624.00
- Revenue This Year
- ASRT N/A
- MYO $55.29
- Revenue Next Year
- ASRT $11.91
- MYO $27.18
- P/E Ratio
- ASRT N/A
- MYO N/A
- Revenue Growth
- ASRT N/A
- MYO 97.60
- 52 Week Low
- ASRT $0.51
- MYO $2.02
- 52 Week High
- ASRT $1.80
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- ASRT 53.64
- MYO 23.46
- Support Level
- ASRT $0.63
- MYO $2.02
- Resistance Level
- ASRT $0.68
- MYO $2.89
- Average True Range (ATR)
- ASRT 0.03
- MYO 0.15
- MACD
- ASRT 0.00
- MYO -0.00
- Stochastic Oscillator
- ASRT 74.71
- MYO 12.09
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).